Allergies can be more than just a seasonal problem – for many people, they are a daily struggle. Sneezing, watery eyes, blocked nose, or difficulty in breathing not only disturbs comfort but also affects work and sleep quality. That’s where FEXOFAB M tablets, a powerful combination of Fexofenadine 120 mg and Montelukast 10 mg, step in as an effective solution. Manufactured under strict WHO-GMP guidelines, FEXOFAB M ensures safety, quality, and reliable relief for patients dealing with allergies and respiratory problems.
What is FEXOFAB M?
FEXOFAB M is a scientifically formulated combination of two powerful anti-allergic medicines:
- Fexofenadine (120 mg): A modern, non-drowsy antihistamine that blocks the effects of histamine, responsible for symptoms like sneezing, itching, and runny nose.
- Montelukast (10 mg): A leukotriene receptor antagonist that reduces airway inflammation, prevents nasal congestion, and helps in long-term allergy and asthma management.
Packed in Alu-Alu blister packaging, each tablet is protected from moisture and contamination, ensuring high stability and long shelf life.
Indications & Uses of FEXOFAB M
FEXOFAB M tablets are widely recommended for multiple allergic and respiratory conditions, including:
- Seasonal Allergic Rhinitis (Hay Fever): Relief from sneezing, itchy eyes, and nasal discharge during seasonal changes.
- Perennial Allergic Rhinitis: Effective in year-round allergies caused by dust, pollen, mold, or pet dander.
- Chronic Urticaria (Hives): Reduces skin rashes, itching, and swelling.
- Asthma (Adjunct Therapy): Montelukast helps control mild asthma symptoms and improves breathing.
- Nasal Congestion & Sinus Allergies: Provides long-lasting relief from blocked nose and sinus pressure.
By targeting both histamine and leukotriene pathways, FEXOFAB M provides broader coverage against allergy symptoms compared to single-drug treatments.
How Does FEXOFAB M Work?
The strength of FEXOFAB M lies in its dual mechanism of action:
- Fexofenadine: Works as a selective H1-receptor blocker, preventing histamine from causing allergy symptoms such as sneezing, itching, and watery eyes. Unlike older antihistamines, it does not cause sedation, allowing patients to remain active throughout the day.
- Montelukast: Blocks leukotrienes, chemicals that cause inflammation in the airways and nasal passages. By reducing this inflammation, Montelukast helps in preventing asthma symptoms, nasal blockage, and breathing difficulties.
Together, this combination ensures comprehensive allergy management – treating not just the symptoms but also preventing recurrence.
Dosage & Administration
- Recommended Dose: One tablet daily for adults and children above 12 years (as advised by the doctor).
- Administration: Can be taken with or without food, preferably at the same time every day.
- Special Considerations: Patients with liver or kidney problems should follow the physician’s guidance on dosage adjustment.
The once-daily dose makes FEXOFAB M convenient, ensuring better patient compliance and consistent relief.
Benefits & Features of FEXOFAB M
FEXOFAB M tablets stand out in the market due to their unique advantages:
- Dual-action therapy – Controls multiple allergy pathways.
- Non-drowsy formulation – Suitable for daytime use.
- Long-lasting effect – 24-hour symptom control.
- Improved breathing & comfort – Especially helpful in allergic asthma.
- Premium packaging – Alu-Alu blister ensures product safety and durability.
These features make it a trusted prescription choice for healthcare providers and a reliable relief option for patients.
Marketing & Business Edge
With the rising cases of allergies and asthma worldwide, the demand for effective anti-allergic medicines is constantly growing. For PCD Pharma Franchise partners and third-party manufacturers, FEXOFAB M presents a strong business opportunity.
Biomorph Lifesciences provides:
- Competitive and affordable pricing
- Attractive, durable packaging
- High-quality formulation backed by WHO-GMP standards
- Regular supply and timely delivery
- Full promotional and marketing support
This makes FEXOFAB M not just a medicine but a profitable addition to any pharma portfolio.
Conclusion
Living with allergies should not be a lifelong struggle. With FEXOFAB M (Fexofenadine 120 mg + Montelukast 10 mg tablets), patients can experience lasting relief from sneezing, itching, congestion, and even mild asthma symptoms. Its dual-action formula, combined with non-drowsy benefits, makes it a modern and effective choice for allergy management.
For patients, FEXOFAB M offers comfort and confidence. For doctors, it provides reliable results. And for pharma partners, it opens doors to strong growth in the anti-allergic and respiratory segment. Backed by Biomorph Lifesciences’ quality assurance, FEXOFAB M continues to build trust as a dependable anti-allergy solution.